Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Pancreatic Neoplasms 2Neoplasms 2Triple Negative Breast Neoplasms 1Neoplasm Metastasis 1Glioma 1Carcinosarcoma 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Specimen Handling 2Magnetic Resonance Spectroscopy 2Carboplatin 2Biopsy 2trastuzumab deruxtecan 1ribociclib 1pelcitoclax 1cobimetinib 1ceralasertib 1belinostat 1atezolizumab 1TIC10 compound 1Paclitaxel 1LY-2157299 1Fulvestrant 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Carcinosarcoma × LY-2157299 × Clear all
NCT03206177 2024-08-07

Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary

University of Oklahoma

Phase 1 Completed
26 enrolled 13 charts
Sarcoma

Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡